BDVC yields 57.14% · PFE yields 6.20%● Live data
📍 BDVC pulled ahead of the other in Year 1
Combined, BDVC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BDVC + PFE for your $10,000?
Franklin BSP Lending Corporation is a business development company specializing in investing in middle market companies, leverage buyouts, acquisitions, recapitalizations, growth opportunities, venture debt, CLO equity, delayed draw term loans, rescue financing, distressed or turnaround situations, and bridge loans and financing. It invests in the debt and equity of private held companies. It typically prefers to invest in unitranche, senior secured debt, senior unsecured debt, second lien secured debt, equity co-investments, subordinated secured debt, subordinated unsecured debt, mezzanine debt, convertible debt, convertible preferred equity, preferred equity, common equity, warrants. It seeks to invest in business services, energy, general industrial, government, healthcare, software, specialty finance; restaurants, TMT, food and beverage, and consumer products. It prefers to take majority stakes in investments. It invests throughout the United States and Canada. It invests between $1 million and $25 million in established companies with revenues between $5 million and $1000 million and stable operating cash flows. Within middle market loans, the investment size across the BSP private debt platform typically ranges from $25 million to over $250 million in companies with EBITDA between $10 million and $100 million. It seeks to have Board representation or Board Observation rights in its portfolio companies.
Full BDVC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.